Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-01 · accession 0001415889-25-002940 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-04 | 2025-02-01 | ACRS | Monahan Joseph | CSO | M - OptEx | — | +22.2K | 243.3K | +10% | — |
| D | 2025-02-04 | 2025-02-01 | ACRS | Monahan Joseph | CSO | F - Tax | $2.48 | -11.3K | 232.0K | -5% | -$28.1K |
| DM | 2025-02-04 | 2025-02-03 | ACRS | Monahan Joseph | CSO | A - Grant | $0.00 | +377.4K | 83.9K | New | $0 |
| DM | 2025-02-04 | 2025-02-01 | ACRS | Monahan Joseph | CSO | M - OptEx | $0.00 | -22.2K | 15.0K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-01 | M | A | 7,500 | — | 228,562 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. |
| 2 | Common | Common Stock | 2025-02-01 | F | D | 11,317 | $2.48 | 231,995 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-01 | M | A | 14,750 | — | 243,312 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2025-02-03 | A | A | 293,500 | $0.00 | 293,500 | D | $2.40 · — to 2035-02-02 | 293,500 Common Stock | (F6) Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. |
| 5 | Derivative | Restricted Stock Units | 2025-02-03 | A | A | 83,900 | $0.00 | 83,900 | D | — · — to — | 83,900 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F5) The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. |
| 6 | Derivative | Restricted Stock Units | 2025-02-01 | M | D | 14,750 | $0.00 | 44,250 | D | — · — to — | 14,750 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F4) The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. |
| 7 | Derivative | Restricted Stock Units | 2025-02-01 | M | D | 7,500 | $0.00 | 15,000 | D | — · — to — | 7,500 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F3) The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. |